BPG is committed to discovery and dissemination of knowledge
Meta-Analysis
Copyright: ©Author(s) 2026.
World J Cardiol. Jul 26, 2026; 18(7): 121611
Published online Jul 26, 2026. doi: 10.4330/wjc.121611
Figure 3
Figure 3 Primary efficacy outcomes. A-C: Dose comparison of olezarsen 80 mg vs 50 mg in regard to reduction in triglyceride level (A), non-high-density lipoproteins cholesterol level (B), and apolipoprotein C-III level (C).


Write to the Help Desk